MindMed Reports Third Quarter 2022 Financial Results and Bus

/PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing...

Related Keywords

Canada , Switzerland , Canadian , Robert Barrow , Development Program Updates , Prnewswire Mind Medicine Mindmed Inc , University Hospital Basel , Nasdaq , Company Annual Report On Form , Exchange Commission , Company Or Mindmed , Medicine Mindmed Inc , Initiated Phase , Generalized Anxiety Disorder , Chief Executive Officer , Program Updates , Anticipated Milestones , Assist Study , Investor Resources , Annual Report , Quarterly Report , Note Regarding Forward Looking Statements , Financial Condition , Consolidated Statements , Mind Medicine Mindmed Inc ,